U.S. IVD & LDT For Autoimmune Diseases Industry Overview
The U.S. IVD and LDT for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach USD 4.74 billion by 2024. The market growth is attributed to rising occurrence of autoimmune diseases & cancers and technological advances in diagnostic techniques. The IVD market in the U.S. is one of the largest due to the high investments made in the R&D, sophisticated healthcare facilities, and increasing awareness about the early diagnosis of these diseases. The American Autoimmune Related Diseases Association, Inc. (AARDA) estimates that around 50 million Americans suffer from autoimmune disorders. It is amongst the top cause of deaths in women in the U.S. There are around more than 80 autoimmune diseases and some commonly occurring ones are rheumatoid arthritis, psoriasis, Grave’s disease, systemic lupus erythematosus, type-1 diabetes, etc. The occurrence of such ailments is expanding, acting as a driving force for the growth of the market in the U.S. Gather more insights about the market drivers, restrains and growth of the U.S. IVD & LDT For Autoimmune Diseases Market These conditions occupy a significant portion of the rising healthcare costs in the U.S. There is a growing need for early diagnosis and preventive screening for these health hazards. The expanding research in molecular diagnostics and adoption of advanced technology in diagnosis are further driving growth. The market is anticipated to further witness growth due to FDA oversight pertaining to the quality and consistency of these tests and several changes in the standards pertaining to the Next-Generation Sequencing (NGS) based tests. Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
U.S. IVD & LDT For Autoimmune Diseases Market Segmentation Grand View Research has segmented the U.S. IVD and LDT for autoimmune diseases market by application and technology: U.S. IVD and LDT for Autoimmune Diseases Market: Application Outlook (Market Revenue in USD Billion, 2013 - 2024)
Key Companies profiled: Some prominent players in the U.S. IVD & LDT for autoimmune diseases market include
Order a free sample PDF of the U.S. IVD & LDT For Autoimmune Diseases Market Intelligence Study, published by Grand View Research.
0 Comments
Protein Purification And Isolation Industry Overview
The global protein purification and isolation market size was valued at USD 7.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.6% from 2022 to 2030. Growing research in the areas of pharmaceutical and biotechnology for the development of novel drugs drives the demand for protein purification and isolation. Furthermore, rising investments in R&D by pharmaceutical manufacturers are projected to drive the market. The unexpected COVID-19 outbreak prompted the implementation of lockdown rules across the globe, causing delays in protein purification and isolation import and export. The pandemic also lowered the availability of funds from private investors and governments around the world. Purification and isolation of proteins refer to a set of procedures for isolating a specific protein from a complicated combination of cells, organisms, or tissues. Gather more insights about the market drivers, restrains and growth of the Global Protein Purification And Isolation Market Protein research requires these techniques to separate, concentrate, stabilize, and eliminate contaminants including endotoxins, viruses, and nucleic acid. They involve determining material and maintaining a purification table to track the enzyme's development. They are mostly used to classify a protein's function, structure, and interactions. Affinity chromatography, immunoprecipitation, proteomics, and enzyme assay are some of the regularly utilized methods of protein purification and separation. Over the pandemic, the disruption in the process had a negative impact on the market, but increased government funding for R&D is enabling the market to recover, and the market is expected to grow during the forecast period. Governments are increasingly investing in R&D and undertaking initiatives that promote the development and growth of the pharmaceutical and biotechnology markets. They also provided added benefits via tax incentives, grants, and investment-friendly regulations among others. Pharmaceutical is a highly lucrative industry for protein purification and isolation solutions owing to significant investments in the development of biomarker-specific molecules. Precise isolation of proteins with a significant amount of purified substrate is a vital component of the preclinical drug development phase. Ongoing technological advancements further drive the market for protein purification and isolation solutions. Magnetic and protein beads and ligand tagging systems are increasingly preferred over traditional methods such as agarose beads and other resins. Furthermore, the rising usage of automated analyzers is projected to drive the demand for purification and isolation solutions. The rising significance of discovering novel ligands, such as protein-based therapeutic compounds, is a major factor fueling the market expansion. Additionally, rising demand for purification kits in rapid screen tests, a shift towards technologically advanced instrumentation for protein purification, growth of the proteomics market, and increasing R&D in pharmaceutical and biotechnological fields are expected to propel the market growth. However, instruments that result in a reduced acceptance rate, the difficulty of maintaining purification kits that fit all proposes, and high tool costs are acting as hurdles to market growth. In addition, the protein purification and isolation industry is benefiting from untapped growth markets and protein therapies. Browse through Grand View Research's Biotechnology Industry Research Reports.
Protein Purification And Isolation Market Segmentation Grand View Research has segmented the global protein purification and isolation market based on product, technology, application, end use, and region: Protein Purification And Isolation Product Outlook (Revenue, USD Million, 2017 - 2030)
Market Share Insights
Key Companies profiled: Some prominent players in the global protein purification and isolation market include
Order a free sample PDF of the Protein Purification And Isolation Market Intelligence Study, published by Grand View Research. Companion Animal Health Industry Overview
The global companion animal health market size was valued at USD 18.67 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2021 to 2028. A rise in the initiatives by the government and private sectors to help promote animal health is anticipated to drive market growth during the forecast period. The One Health Initiative is one such collaborative effort undertaken by multiple organizations. These include the World Organization for Animal Health (OIE), Food and Agriculture Organization (FAO), WHO, the American Veterinary Medical Association, and others. It is aimed at protecting public health via the prevention and control of zoonotic pathogens by safeguarding animal health. It is carried out through the implementation of appropriate policies at national, regional, and global levels. Gather more insights about the market drivers, restrains and growth of the Global Companion Animal Health market The Covid-19 pandemic had a notable impact on the industry. Companies had to adapt to the challenging circumstances while facing operational and logistics hurdles. However, many market players leveraged the opportunity to increase profits and market share. For example, Vetoquinol S.A.reported an overall increase in 2020 sales compared to the previous year. This growth was driven by its essentials comprising veterinary drugs and non-medical products. Driven by the increasing humanization of pets, the expenditure on pet health and wellness is also on the rise. In 2019, in Australia, more than USD 2.6 billion was spent on animal health services as per Animal Medicines Australia. This trend was estimated to continue in the near future. The top reasons cited for veterinary visits were general health checkups, pathology & lab tests, vaccinations, illness or injury, X-ray & imaging, hospitalization, and others. Increasing availability and adoption of pet health insurance is another factor propelling the market growth. The company estimated that only 3% of the pet dogs and cats population in Hong Kong was insured, even though veterinary care costs were high in the country. The company projected more and more pet owners would opt for pet health insurance in the coming years. Browse through Grand View Research's Animal Health Industry Research Reports.
Companion Animal Health Market Segmentation Grand View Research has segmented the global companion animal health market on the basis of animal type, product, distribution channel, end-use, and region: Companion Animal Health Animal Type Outlook (Revenue, USD Million, 2016 - 2028)
Market Share Insights
Key Companies profiled: Some prominent players in the global companion animal health market include
Order a free sample PDF of the Companion Animal Health Market Intelligence Study, published by Grand View Research. Active Pharmaceutical Ingredients Industry Overview
The global active pharmaceutical ingredients market size was valued at USD 187.76 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028. The growth can be attributed to the advancements in active pharmaceutical ingredient (API) manufacturing and the rising prevalence of chronic diseases, such as cardiovascular diseases and cancer. Favorable government policies for API production, along with changes in geopolitical situations, are boosting the market growth. The API market is undergoing immense changes due to supply chain disruption by COVID-19. Countries such as India are being preferred over China for the export of API owing to geopolitical situations and the demand to reduce dependence on China for API products. Furthermore, governments of many countries have formulated plans and granted incentives to promote the production of API. Gather more insights about the market drivers, restrains and growth of the Global Active Pharmaceutical Ingredients Market The global geriatric population is rising. According to the UN, in 2017, the population aged 65 and above is anticipated to increase from 962 million in 2017 to 2.1 billion by 2050. Aging weakens the immune system and increases a patient’s susceptibility to acquiring infectious diseases. Moreover, impairment in body functions enhances the chances of getting other diseases, such as CVD and diabetes. The requirement of high capital for the production of APIs is because the process needs extremely systematic protocols, which results in the outsourcing of various APIs. In addition, pharmaceutical companies benefit from API production outsourcing as it eradicates the need for expensive manufacturing unit installation and labor force. Thus, the need for cost savings boosts outsourcing. Strategic outsourcing by companies allows them to focus on core competencies, which results in increased productivity. In addition, APIs are used as Antibody Drug Conjugates (ADCs). ADCs are important and effective treatment modalities used in combination with biologically active drugs and monoclonal antibodies for cancer. APIs effectively target cancer cells, while causing minimum exposure of drugs to healthy tissues. Thus, the development of cancer-specific APIs is expected to boost the API market growth. Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Active Pharmaceutical Ingredients Market Segmentation Grand View Research has segmented the global active pharmaceutical ingredients market report on the basis of the type of synthesis, type of manufacturer, type, application, and region:
Market Share Insights
Key Companies profiled: Some prominent players in the global active pharmaceutical ingredients market include:
Order a free sample PDF of the Active Pharmaceutical Ingredients Market Intelligence Study, published by Grand View Research. Legal Marijuana Industry Overview
The global legal marijuana market size was valued at USD 13.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 25.5% from 2022 to 2030. The growing demand for legal marijuana has been a primary factor in the growth of the market. Recently, a large number of countries have legalized the use of medical marijuana for treating various ailments. A number of studies carried out show that medical marijuana and its derivatives can be used to treat symptoms of various diseases, for e.g., it has been successfully used to treat patients with chronic pain, chemotherapy-induced nausea, Parkinson’s, Alzheimer’s, and other neurological diseases. The FDA and other such associations have now started accepting the marijuana derivatives for the prescription of diseases in which it has proven to be useful. This is another factor for the quick turnaround of its legal status in a lot of countries. North America (the U.S. and Canada) has gone a step further and has sanctioned the use of recreational marijuana as well and more than two-thirds of the U.S. states have legalized marijuana. Gather more insights about the market drivers, restrains and growth of the Global Legal Marijuana Market The pandemic severely affected the logistics network for cannabis and its derivatives and due to the ongoing restrictions, the government authorized dispensaries are also facing shortages owing to disruption in the supply chain network. Import and export of nearly all commodities essential or not have been affected as well. However, with the governments endorsing legalization, the demand has risen and is likely to be high in the next few years. Patients are opting for marijuana derivatives instead of the prescription medicines previously being used. With the government policies changing, the demand for medical marijuana is also rising. A lot of countries that have legalized the use of medical marijuana are also paving way for its cultivation to cut on the imports and gain revenue in the form of taxes. This, in turn, has generated jobs in the industry and a lot more companies are dabbling in this territory. Several startups in the U.S. and Europe are now focusing on alternate uses of cannabis, other than recreational and medicinal. With so much happening in and around the cannabis industries, the countries are paving way for more liberal policies regarding its cultivation and usage in the medical field as well as industrial use. Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Legal Marijuana Market Segmentation Grand View Research has segmented the global legal marijuana market report based on product type, application, and region:
Key Companies profiled: Some prominent players in the global legal marijuana market include:
Order a free sample PDF of the Legal Marijuana Market Intelligence Study, published by Grand View Research. Cochlear Implant Market Is Expected To Expand Due To Growing Prevalence Of Hearing Loss Till 20306/3/2022 Cochlear Implant Industry Overview
The global cochlear implant market size was valued at USD 1.5 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.71% from 2022 to 2030. The growing prevalence of hearing loss and increase in adoption due to technological advancements are the factors expected to drive the growth of the market. According to World Health Organization (WHO) statistics 2021, approximately 5.0% of the global population (430 million people) undergoes rehabilitation to aid their loss of hearing. Over 2.5 billion individuals are estimated to suffer from some degree of hearing loss by 2050. Hearing loss has become a major concern in the past few years and can be attributed to various factors including genetic factors, intrauterine infections, birth asphyxia, cerumen impaction, ototoxic medications, and others. These people can benefit from assistive devices including cochlear implants, hearing aids, and others. Favorable reimbursement, the introduction of minimally invasive procedures, and technological advancements are boosting the adoption of cochlear implants. Gather more insights about the market drivers, restrains and growth of the Global Cochlear Implant Market Several initiatives are being undertaken by the government and various organizations to support research in the field of cochlear implantation. For instance, in March 2022 members of the American Cochlear Implant (ACI) Alliance shared research and clinical practice with the other community members at the 2022 American Academy of Audiology (AAA) conference. The conference was organized to connect with peers in the community, stay updated with upcoming information, and know about recent developments in the audiological industry. This is likely to favor the cochlear implant market growth. Moreover, the rising geriatric population is expected to propel the growth of the cochlear implants market. According to World Health Organization (WHO), the population aged 60 years and above is accounted for above 1.0 billion in 2020 and is estimated to reach 1.4 billion by 2050. As hearing ability decreases with the age, an increase in the age population is expected to bode well with the market. The onset of COVID-19 imposed restrictions on audiology surgery and treatment services. While drilling in the mastoid cavity, the probability of aerosolizing the virus posed a greater risk of contamination during neurotological (subcategory of ENT) surgeries. This led to the screening of patients for COVID-19 prior to surgery, which delayed the surgical treatments. Additionally, the children with cochlear implants require Auditory-Verbal Therapy (AVT) at least during the initial 2 years of the implantation, to better understand the auditory information and to learn speech-language skills. Moreover, appointments for the rehabilitation process after surgery were also postponed or delayed. However, surgeries resumed gradually at a different pace in accordance with the relaxations on COVID-19 restrictions in different countries. With the help of telemedicine, audiology surgeries and treatment methods are recovering gradually from the adverse impact of COVID-19. Browse through Grand View Research's Medical Devices Industry Research Reports.
Cochlear Implant Market Segmentation Grand View Research has segmented the global Cochlear Implant Market Report based on the type of fittings, end-use, and region:
Market Share Insights
Key Companies profiled: Some of the prominent players in the global cochlear implant market include:
Order a free sample PDF of the Cochlear Implant Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Latin America Nutritional Supplements Market Is Projected To Reach USD 97.3 Billion By 20306/2/2022 Latin America Nutrition & Dietary Supplements Industry Overview
The Latin American nutrition and dietary supplements market size was valued at USD 22.01 billion in 2016. It is projected to expand at a CAGR of 8.8% over the forecast period. Increasing prevalence of chronic diseases, geriatric population, and a trend of active living are the key driving factors. Growing disposable income is also a considerable factor positively impacting the market. According to the U.S. Census Bureau, the geriatric population in Latin America and the Caribbean was nearly 47 million in 2015 and is projected to surpass 82.5 million by 2030. Deficiency of essential nutrients such as vitamin D is high among the elderly population owing to reduced dietary intake, impaired intestinal absorption, and diminished sunlight exposure. Thus, the demand for nutrition and dietary supplements is expected to increase among this population subset in the coming years. Gather more insights about the market drivers, restrains and growth of the Latin America Nutrition & Dietary Supplements Market Although overall nutritional status has improved significantly, more initiatives are required to address public health concerns such as malnutrition, vitamin A deficiency, anemia, and stunting. Various public and private organizations are undertaking initiatives to address these health concerns in Latin America. Thus, the demand for nutrient and dietary supplements is projected to rise in this region. Nutrition International (formerly referred to as Micronutrient Initiative) is the NGO dedicated to tackling malnutrition which is the greatest health concern globally. This organization has undertaken initiatives in Central and South American countries such as Guatemala and Bolivia for addressing malnutrition. For instance, the Government of Bolivia initiated a Programa Multisectorial Desnutrición Cero (PMDC) or Multi-Sectoral Zero Malnutrition Program in collaboration with Nutrition International. This program was focused on micronutrient interventions such as the provision of iron-folic acid for lactating and pregnant women, vitamin A for children under five years of age, and multimicronutrient for children of six months to 23 months of age. Obesity is another health challenge in Latin America. According to the estimates published by Lancet, there were around 300 million overweight adults in Latin America in 2014. Out of this, approximately 100 million people were obese. Thus, the demand for nutritional supplements for managing obesity is expected to rise in the forthcoming years. Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Latin America Nutrition & Dietary Supplements Market Segmentation Grand View Research, Inc. has segmented the Latin America nutrition and dietary supplements market report based on function, formulation, consumer, and country:
Key Companies profiled: Some prominent players in the Latin America nutrition & dietary supplements market include:
Order a free sample PDF of the Latin America Nutrition & Dietary Supplements Market Intelligence Study, published by Grand View Research. Antibody Drug Conjugates Market Is Expected To Register A CAGR Of 16.4% During The Forecast Period6/2/2022 Antibody Drug Conjugates Industry Overview
The global antibody drug conjugates market size was valued at USD 5.81 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 16.4% from 2022 to 2030. The market is primarily driven by globally rising incidences of cancer. According to Cancer Research UK estimates the number of new cancer cases worldwide is expected to reach 27.5 million by 2040. Factors such as smoking, unhealthy diet, obesity, and alcohol are the major cause of rising cancer cases, worldwide. The COVID-19 pandemic had a negative impact on the product sale due to the loss of health insurance coverage, decrease in hospital visits, and lower diagnosis rates. The unavailability of participants for clinical trial studies led to a delay in the potential approval of ADCs such as Adcetris for other indications. Gather more insights about the market drivers, restrains and growth of the Global Antibody Drug Conjugates Market Increasing investment in this field by the key players such as Piramal Pharma Solution, Pfizer Inc., Seagen Inc., and F. Hoffman La-Roche Ltd for the development of new ADCs intended for the treatment of cancer is expected to drive the market growth. For instance, in February 2022, CDMO Piramal Pharma Solutions (PPS) invested about USD 74.6 million in the development of two new antibody-drug conjugates (ADC) production facilities at its existing sites in Grange mouth, Scotland to fulfill the growing demand for commercial ADCs in UK. This investment strengthens PPS’ position in the market, significantly, by increasing ADC manufacturing capacity. Most of the companies are conducting clinical trials to bring new products to the market and to gain label expansion for their already approved products. For instance, in January 2022, Seagen initiated phase-1 clinical trials of two novel antibody-drug conjugates such as SGN-B7H4V & SGN-PDL1V in patients with advanced solid tumors. In addition, the company in collaboration with Astellas completed enrollment of the patients for cohort K EV-103 trial used for the treatment of First-Line Metastatic Urothelial Cancer (mUC). Successful completion of the clinical trial study and subsequent approval of the products is expected to drive market growth. Browse through Grand View Research's Pharmaceuticals Industry Research Reports.
Antibody Drug Conjugates Market Segmentation Grand View Research has segmented the global antibody drug conjugates market report based on the application, technology, and region:
Market Share Insights
Key Companies profiled: Some of the prominent players in the global antibody drug conjugates market include:
Order a free sample PDF of the Antibody Drug Conjugates Market Intelligence Study, published by Grand View Research. Healthcare Contract Development And Manufacturing Organization Industry Overview
The global healthcare contract development and manufacturing organization market size was valued at USD 217.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030. An increase in uptake of outsourcing services by pharmaceutical companies and growth in R&D investments are expected to drive the market. Medical devices & pharmaceutical companies are outsourcing low-end services to reduce the overall cost of production. This trend is expected to contribute to the growth of the market for healthcare contract development and manufacturing organization (CDMO), in the forecast period. The presence of end-to-end service providers that offer value-added services for an integrated or risk-sharing business model is expected to bolster market growth. The COVID-19 pandemic has significantly impacted the global economy in 2020 and has had an ongoing impact on various industries. However, the market for healthcare contract development and manufacturing organization (CDMO) witnessed a positive impact due to this pandemic. CDMOs are playing an important role in meeting the needs of pharmaceutical companies, biotech companies, and other end-users during this crisis. For instance, Lonza signed a 10-year manufacturing contract with Moderna for manufacturing the COVID-19 vaccine. CDMO players are offering pharma, biotech, and other end-user companies cost-efficiency, time-saving, and specialized expertise. The rapid rise in demand for COVID-19 vaccines and therapeutics is propelling the IND CDMO market. Even post-pandemic, the future seems upright for the IND CDMO market owing to the robust drug pipeline of pharmaceutical and biotech companies. Gather more insights about the market drivers, restrains and growth of the Global Healthcare Contract Development And Manufacturing Organization Market According to the 2019 PhRMA member annual survey, pharmaceutical companies invested USD 79.6 billion in R&D. As the healthcare industry is undergoing a process of dynamic change, factors such as rapid technological advancements (e.g., automation & artificial intelligence), the need for CROs/CMOs/CDMOs, and rising investments in research are influencing the healthcare market. Outsourcing activities are befitting many pharmaceutical companies in improving operational efficiencies, expanding geographical presence, decreasing resource costs, gaining therapeutic expertise, and enhancing on-demand services. Medical device companies are focusing on emerging countries to gain access to newer markets and increase their revenues. OEM consolidation has also boosted the overall medical devices contract manufacturing market. For pharmaceutical companies, increasing R&D costs is a challenge, which significantly affects their bottom line therefore they have partnered with CROs & CMOs for integrated outsourcing services. Outsourcing research activities to CMO or CDMO helps accelerate the workflow of companies, provide unique specialized services, decrease drug development costs, and provide the expertise & experience needed for assisting research. For many pharmaceutical companies, innovations and speed-to-clinic factors are of critical importance. Small companies and specialty pharmaceutical players increasingly rely upon delivering these important requirements within the industry. Many CROs and CDMOs promote themselves as one-stop-shop companies. The one-stop-shop service model is where a CRO handles everything from API to dosage form and early development to commercialization. To provide these services, a CDMO must have a wide range of enabling technologies and specialized handling capabilities to address specific problem statements. Although these services address many problem statements, there is a wide range of product design capabilities among CDMO players that can be critical in scaling a product concept and bringing it to the market. Browse through Grand View Research's Medical Devices Industry Research Reports.
Healthcare Contract Development And Manufacturing Organization Market Segmentation Grand View Research has segmented the global pharmaceutical contract manufacturing and research services market report on the basis of service and region: Healthcare Contract Development And Manufacturing Organization Services Outlook (Revenue, USD Billion, 2018 - 2030)
Healthcare Contract Development And Manufacturing Organization Regional Outlook (Revenue, USD Billion, 2018 - 2030)
Market Share Insights
Key Companies profiled: Some prominent players in the healthcare contract development and manufacturing organization market include:
Order a free sample PDF of the Healthcare Contract Development And Manufacturing Organization Market Intelligence Study, published by Grand View Research. |
Archives
December 2023
Categories |